Literature DB >> 17361252

Surgical macular decompression for macular edema in retinal vein occlusion.

Mark S Mandelcorn1, Efrem Mandelcorn, Kit Guan, Feisal A Adatia.   

Abstract

BACKGROUND: Recently, a number of surgical and laser approaches have been used to improve visual outcome in cases of central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). Intravitreal steroid injection alone appears to offer only temporary improvement at best. Radial optic neurotomy for CRVO and arteriovenous adventitial sheathotomy for BRVO are the most frequently utilized surgical procedures for these conditions, but evidence regarding efficacy is still lacking. We have suggested that macular decompression by internal limiting membrane (ILM) peeling may reduce macular edema and hemorrhage and improve visual acuity by relieving elevated intraretinal tissue pressure and facilitating egress of blood and extracellular fluid out of inner retinal layers into the vitrectomized vitreous cavity.
METHODS: 50 cases of severe visual loss due to macular edema caused by CRVO or BRVO, not eligible for laser photocoagulation, underwent pars plana vitrectomy with removal of preretinal hyaloid, peeling of the ILM stained with indocyanine green dye, air-fluid exchange, and postoperative prone positioning.
RESULTS: In all cases, intraretinal blood and retinal thickening diminished within 6 weeks of surgery. Visual acuity improved in 87% of CRVO cases and 68% of BRVO cases. Vision improved and stabilized at 39 days after surgery. Average improvement was 2.6 lines with a 6-line improvement in 1 case. There was no difference in outcome between cases with ischemic or nonischemic features on fluorescein angiography.
INTERPRETATION: Macular decompression using vitrectomy and ILM peeling is effective in the treatment of severe visual loss due to macular edema in CRVO and in those BRVO cases that do not qualify for laser photocoagulation.

Entities:  

Mesh:

Year:  2007        PMID: 17361252     DOI: 10.3129/can j ophthalmol.06-091

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  11 in total

1.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

Review 2.  Physiology of vitreous surgery.

Authors:  Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

Review 3.  Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.

Authors:  Dina Gewaily; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

Review 4.  Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.

Authors:  Dina Gewaily; Karthikeyan Muthuswamy; Paul B Greenberg
Journal:  Cochrane Database Syst Rev       Date:  2015-09-09

5.  Histopathologic and electron microscopic features of internal limiting membranes in maculopathies of various etiologies.

Authors:  Mozhgan Rezaei Kanavi; Masoud Soheilian
Journal:  J Ophthalmic Vis Res       Date:  2014-04

6.  Pars plana vitrectomy combined with internal limiting membrane peeling for recurrent macular edema due to branch retinal vein occlusion after antivascular endothelial growth factor treatments.

Authors:  Yukari Shirakata; Kouki Fukuda; Tomoyoshi Fujita; Yuki Nakano; Hiroyuki Nomoto; Hidetaka Yamaji; Fumio Shiraga; Akitaka Tsujikawa
Journal:  Clin Ophthalmol       Date:  2016-02-05

7.  Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion.

Authors:  Pina Fortunato; Liliana Pollazzi; Maurizio Baroni; Attilio Evangelisti; Agostino La Torre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-16       Impact factor: 3.117

Review 8.  Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.

Authors:  Jiri Rehak; Matus Rehak
Journal:  Curr Eye Res       Date:  2008-02       Impact factor: 2.424

Review 9.  Inflammation and macular oedema after pars plana vitrectomy.

Authors:  Vito Romano; Martina Angi; Fabrizio Scotti; Renata del Grosso; Davide Romano; Francesco Semeraro; Paolo Vinciguerra; Ciro Costagliola; Mario R Romano
Journal:  Mediators Inflamm       Date:  2013-10-30       Impact factor: 4.711

10.  Pars Plana Vitrectomy Combined with Internal Limiting Membrane Peeling to Treat Persistent Macular Edema after Anti-Vascular Endothelial Growth Factor Treatment in Cases of Ischemic Central Retinal Vein Occlusion.

Authors:  Yukari Shirakata; Tomoyoshi Fujita; Yuki Nakano; Fumio Shiraga; Akitaka Tsujikawa
Journal:  Case Rep Ophthalmol       Date:  2016-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.